跳至主要内容
临床试验/CTRI/2022/06/043277
CTRI/2022/06/043277尚未招募4 期

Buprenorphine as an adjuvant to 0.5% Ropivacaine for supraclavicular brachial plexus block: A randomized, prospective study

Mrigakshi Sarma0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. American Society of Anaesthesiology(ASA) physical status I and II.
  • 2.Scheduled for elective Orthopaedic upper limb surgery under supraclavicular brachial plexus block.
  • 3. Informed and written consent.

排除标准

  • 1.Unwilling patients.
  • 2.Patients belonging to ASA physical status III or more.
  • 3. Patients with known hypersensitivity to local anaesthetics.
  • 4.Infection at the site of block.
  • 5.Patients with known coagulopathy or patients on anticoagulation therapy.

研究者

发起方
Mrigakshi Sarma

相似试验